-18,PSMA

Changjiang Wang1,2, Ruiling Long1,2, Mei Hu1,2

  • 1Department of Nuclear Medicine, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou, Sichuan, China.

PubMed
概括

新的18F标记的放射性追踪剂[18F]4a显示出高稳定性和瘤吸收率,用于前列腺癌 (PCa) 诊断. 这种针对PSMA的药物在临床前模型中表现出与68Ga-PSMA-11相比更高的性能.